WO2023203477 - INSULIN MANAGEMENT FOR DELIVERING INSULIN DURING A FASTING PERIOD
National phase entry:
Publication Number
WO/2023/203477
Publication Date
26.10.2023
International Application No.
PCT/IB2023/053950
International Filing Date
18.04.2023
Title **
[English]
INSULIN MANAGEMENT FOR DELIVERING INSULIN DURING A FASTING PERIOD
[French]
GESTION DE L'INSULINE POUR ADMINISTRER DE L'INSULINE PENDANT UNE PÉRIODE DE JEÛNE
Applicants **
LUNA HEALTH, INC.
Inventors
SJÖLUND, Per John
PRYOR, Jack David
SAINT, Sean Thomas
DESBOROUGH, Lane
Priority Data
63/332,001
18.04.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3728 | |
| EPO | Filing, Examination, Granting | 29303 | |
| Japan | Filing, Examination, Granting | 3292 | |
| South Korea | Filing, Examination, Granting | 4576 | |
| USA | Filing, Examination, Granting | 12190 |
Total:
53,089
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
According to some embodiments, an insulin management method implemented by an insulin delivery system including an insulin delivery device (130). The method includes: determining (154, 225) an assumed insulin on board based on an assumed external dose calculated to correct an initial blood glucose value of the user to a target blood glucose; and delivering (152, 233) insulin from the insulin delivery device (130) with the insulin in the form of a plurality of correction bolus doses during a fasting period in response to received blood glucose measurements, the correction bolus doses compensated for by a determined insulin on board, wherein for at least a first correction bolus dose of the plurality of correction bolus doses the determined insulin on board equals the assumed insulin on board.[French]
Certains modes de réalisation de l'invention concernent un procédé de gestion d'insuline mis en œuvre par un système d'administration d'insuline comprenant un dispositif d'administration d'insuline (130). Le procédé comprend les étapes suivantes : détermination (154, 225) d'une insuline active supposée sur la base d'une dose externe supposée calculée pour corriger une valeur de glycémie initiale de l'utilisateur à une glycémie cible ; et administration (152, 233) de l'insuline à partir du dispositif d'administration d'insuline (130) avec l'insuline sous la forme d'une pluralité de doses de bolus de correction pendant une période de jeûne en réponse à des mesures de glycémie reçues, les doses de bolus de correction étant compensées par une insuline active déterminée, l'insuline active déterminée étant égale à l'insuline active supposée pour au moins une première dose de bolus de correction de la pluralité de doses de bolus de correction.